Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

NCT02464709 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratosis
Natural Daylight Photodynamic Therapy

Interventions

DRUG: Aminolevulinic Acid
DRUG: Methyl 5-aminolevulinate

Sponsor

Joint Authority for Päijät-Häme Social and Health Care

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]